HOUSTON--(BUSINESS WIRE)--CytoGenix, Inc. (OTCBB:CYGX) announced today completion of the first Supply Agreement to provide DNA products to one of its customers. Under the Agreement, the customer will purchase its entire requirements of DNA products from CytoGenix for the term of the Agreement. The customer will provide CytoGenix with flexible one (1) year and quarterly forecasts representing the customer’s needs for multiple key DNA constructs of the type and quantity of DNA products that the customer expects to purchase in each of the next four calendar quarters.